Menopur

Menotropin, the active ingredient in Menopur, is a gonadotropin presented as a powder for solution for injection for intramuscular or subcutaneous use. It stimulates follicular development and ovulation, addressing infertility due to anovulation and supporting controlled ovarian hyperstimulation in assisted reproductive technology cycles.

GNH USA supplies Menopur as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The product conforms to EU regulatory standards and is distributed under strict quality‑assurance protocols.

Menopur (menotropin) acts on the hypothalamic‑pituitary‑gonadal axis to support ovarian stimulation.

- Infertility due to anovulation: promotes follicular growth and induces ovulation in women who do not ovulate spontaneously. - Controlled ovarian hyperstimulation for assisted reproductive technology: enhances the number of mature oocytes retrieved during IVF or ICSI cycles. - Ovulation induction in polycystic ovary syndrome: facilitates follicular development to achieve timed ovulation.

Menopur may cause a range of adverse reactions, which vary in frequency and severity.

Common Side Effects: - Injection site pain or erythema - Abdominal discomfort or bloating - Mild headache - Nausea or vomiting - Mild ovarian hyperstimulation syndrome (OHSS) - Mood changes or irritability

Serious or Rare Side Effects: - Severe ovarian hyperstimulation syndrome - Multiple pregnancy (twins, triplets, etc.) - Thromboembolic events (deep vein thrombosis, pulmonary embolism) - Allergic reaction or anaphylaxis - Ovarian torsion - Ectopic pregnancy

Before initiating Menopur therapy, several safety considerations should be observed.

- Dose individualization: dosing is individualized by the treating physician based on ovarian response. - Monitor ovarian response: regular ultrasound and estradiol monitoring are required. - Risk of ovarian hyperstimulation syndrome: patients should be educated on symptoms and seek prompt care if they occur. - Avoid use in uncontrolled thyroid or adrenal disease: hormonal imbalances may affect treatment efficacy. - Pregnancy testing: confirm non‑pregnant status before initiating therapy. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Menopur can interact with other medications that influence hormonal balance or coagulation.

Major Interactions (Avoid): - GnRH agonists or antagonists: concurrent use may alter ovarian response. - Hormonal contraceptives: may suppress the intended ovulatory effect. - Thyroid hormone replacement: uncontrolled levels may affect treatment outcome.

Moderate Interactions (Monitor Closely): - Anticoagulants: increased risk of ovarian cyst rupture bleeding. - Corticosteroids: may affect hormone metabolism and response. - Insulin or oral hypoglycemics: monitor glucose as hormonal changes can affect glycaemia.